Patents by Inventor Hector W. Alila

Hector W. Alila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating a patient with neoplasia using Iressa
    Patent number: 6906064
    Abstract: This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an inhibitor of human epidermal growth factor receptor tyrosine kinase and a cGMP-specific phosphodiesterase inhibitor.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: June 14, 2005
    Inventors: W. Joseph Thompson, Hector W. Alila
  • Methods for treatment of inflammatory bowel disease
    Patent number: 6699894
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of inflammatory bowel disease.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: March 2, 2004
    Assignee: OSI Pharmaceuticals, Inc.
    Inventors: Keith A. Earle, Hector W. Alila
  • Method for treating a patient with neoplasia using Iressa
    Publication number: 20030232862
    Abstract: This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with an inhibitor of human epidermal growth factor receptor tyrosine kinase and a cGMP-specific phosphodiesterase inhibitor.
    Type: Application
    Filed: June 10, 2002
    Publication date: December 18, 2003
    Inventors: W. Joseph Thompson, Hector W. Alila
  • Methods for treatment of rheumatoid arthritis
    Publication number: 20030176316
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of rheumatoid arthritis.
    Type: Application
    Filed: October 23, 2002
    Publication date: September 18, 2003
    Inventors: Clark M. Whitehead, Keith A. Earle, Hector W. Alila, W. Joseph Thompson
  • Methods for treatment of multiple sclerosis
    Publication number: 20030073741
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of multiple sclerosis.
    Type: Application
    Filed: May 21, 2002
    Publication date: April 17, 2003
    Inventors: Clark M. Whitehead, Keith A. Earle, Hector W. Alila, W. Joseph Thompson
  • Methods for treatment of lupus erythematosus
    Publication number: 20030073740
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of lupus erythematosus.
    Type: Application
    Filed: August 23, 2001
    Publication date: April 17, 2003
    Inventors: Clark M. Whitehead, Keith A. Earle, Hector W. Alila, W. Joseph Thompson
  • Methods for treatment of scleroderma
    Publication number: 20030073711
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of scleroderma.
    Type: Application
    Filed: August 23, 2001
    Publication date: April 17, 2003
    Inventors: Clark M. Whitehead, Keith A. Earle, Hector W. Alila, W. Joseph Thompson
  • Methods for treatment of type I diabetes
    Patent number: 6479493
    Abstract: Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: November 12, 2002
    Assignee: Cell Pathways, Inc.
    Inventors: Clark M. Whitehead, Keith A. Earle, Hector W. Alila, W. Joseph Thompson
  • Methods for treatment of cystic fibrosis
    Patent number: 6465494
    Abstract: Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of cystic fibrosis.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: October 15, 2002
    Assignee: Cell Pathways, Inc.
    Inventors: Keith A. Earle, Hector W. Alila, Clark M. Whitehead, W. Joseph Thompson
  • Reduction of boar odor in meat
    Patent number: 5604214
    Abstract: This invention relates to a method for eliminating or lessening the incidence of boar odor in meat reared from male pigs which comprises administering to such male pigs an effective amount of a boar 4-ene-5-.alpha.-reductase inhibiting compound with or without further active ingredients. Also provided is a method for preventing the formation of 5-.alpha.-androst-16-en-3-one in male pigs which comprises administering to such male pigs a presently discovered boar 4-ene-5-.alpha.-reductase inhibiting compound.
    Type: Grant
    Filed: October 20, 1995
    Date of Patent: February 18, 1997
    Assignee: Pfizer Inc.
    Inventors: Hector W. Alila, Michael T. Clark, Richard D. Hedde, Mark A. Levy, Thomas O. Lindsey